Presentation and survival time of domestic ferrets (Mustela putorius furo) with lymphoma treated with single- and multiagent protocols: 44 cases (1998–2016)

THE MANAGEMENT OF LYMPHOPROLIFERATIVE NEOPLASIA IN FOUR NORTHERN SEA OTTERS (ENHYDRA LUTRIS KENYONI)

Lymphoproliferative neoplasia has been reported in both free-ranging sea otters and those in managed care, but little information is available on the management of this neoplastic disease in this species. This case series describes clinical lymphoma in four northern sea otters (Enhydra lutris kenyoni) in managed care. Two otters presented with Stage 5 lymphoma with evidence of hematologic spread resulting in leukemia. Two additional otters presented with Stage 3 disease. Immunophenotypes in these cases included disseminated large B-cell lymphoma and lymphoblastic lymphoma of potential T-cell origin. Cases were managed with multiagent chemotherapy protocols including prednisone, L-asparaginase, cyclophosphamide, vincristine, cytosine arabinoside, lomustine, and doxorubicin. Unique approaches included the use of a vascular access port in one case and development of an autologous vaccine in another. Survival time ranged from 81 to 409 days. Diagnosis, staging, and treatment with multiagent protocols is recommended for the management of lymphoma in sea otters.

Respiratory Disorders in Ferrets

Ferrets are susceptible to many disorders affecting the respiratory tract including both primary diseases and diseases of other body systems secondarily affecting the respiratory tract. Some primary respiratory diseases are shared with other mammal species including humans; potentially zoonotic diseases include important pathogens such as influenza and SARS-CoV-2. Other diseases include infections (bacterial, parasitic, and fungal) and neoplasia. A thorough workup is important to identify exact causes in order to formulate a treatment plan. Infectious diseases include bacterial, fungal, parasitic, and viral.